Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantationBruno Paiva, Jesús F. San Miguel, Norma C. Gutiérrez et al.|Blood|2008Cited by 479
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer SurvivalJuan José Lahuerta, Jesús F. San Miguel, María‐Victoria Mateos et al.|Journal of Clinical Oncology|2008Cited by 282
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myelomaLaura Rosiñol, Joan Bladé, Josè Antonio Pérez-Simón et al.|Blood|2008Cited by 264
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patientsBruno Paiva, María‐Belén Vídriales, Gema Mateo et al.|Blood|2009Cited by 75
Prolonged survival of patients with angioimmunoblastic T‐cell lymphoma after high‐dose chemotherapy and autologous stem cell transplantation. The GELTAMO experienceJosé Rodríguez, Eulogio Conde, Antonio Gutiérrez et al.|European Journal Of Haematology|2007Cited by 60